Preclinical Evaluation of New Anthracyclines
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
9-13
Author(s):
G. Pratesi and S. V. Monestiroli
The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents
Journal:
Current Drug Targets
Volume:
1
Page:
327-364
Author(s):
M. Gardnerova, R. Blanque and C. R. Gardner
Adenosine Receptor Ligands-Recent Developments Part I. Agonists
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1269-1288
Author(s):
C. E. Muller
Controlled Delivery of Biotechnological Products
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
313-323
Author(s):
S. Conti, L. Polonelli, R. Frazzi, M. Artusi, R. Bettini, D. Cocconi and P. Colombo
Chemistry of the Genus Dorstenia
Journal:
Current Organic Chemistry
Volume:
4
Page:
1079-1090
Author(s):
B M. Abegaz, B T. Ngadjui, E Dongo and M T. Bezabih
Oligonucleotide-based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs
Journal:
Current Drug Targets
Volume:
1
Page:
15-23
Author(s):
Ryuichi Morishita, Motokuni Aoki and Yasufumi Keneda
Turnover Studies on Cardiac Natriuretic Peptides: Methodological,Pathophysiological and Therapeutical Considerations.
Journal:
Current Drug Metabolism
Volume:
1
Page:
85-105
Author(s):
Aldo Clerico, Giorgio Iervasi and Alessandro Pilo
Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
1-9
Author(s):
A. J. Grillo-Lopez, C. A. White, B. K. Dallaire, C. L. Varns, C. D. Shen, A. Wei, J. E. Leonard, A. McClure, R. Weaver, S. Cairelli and J. Rosenberg
New Trends in Thromboxane and Prostacyclin Modulators
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
609-628
Author(s):
Jean -Michel Dogne, Xavier de Leval, Jacques Delarge, Jean -Louis David and Bernard initial Masereel
Cytokine Therapy for Cancer
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
681-699
Author(s):
M. Tagawa